SCHEMBL9494856

SCHEMBL9494856

C=CCN1C(=O)C(=C)S/C1=N/N=C1/SCC(=O)N1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 4/20 0.40
▸ TSHR P16473 2/20 0.39
▸ RECQL P46063 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ MEN1 O00255 5/20 0.38
▸ KMT2A Q03164 5/20 0.38
▸ GAA P10253 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ RAB9A P51151 1/20 0.32
▸ GSK3A P49840 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ POLB P06746 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ USP2 O75604 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9494860 1.00 LMNA (0.41) LMNAMAPTTSHRRECQLMAPK1
SCHEMBL9493057 0.87 ALDH1A1 (0.36) LMNATSHRALDH1A1MEN1KMT2A
SCHEMBL9494278 0.85 LMNA (0.52) LMNAMAPTTSHRRECQLMAPK1
SCHEMBL9494274 0.85 LMNA (0.52) LMNAMAPTTSHRRECQLMAPK1
SCHEMBL9493054 0.81 ALDH1A1 (0.37) TSHRALDH1A1MEN1KMT2AGAA
SCHEMBL9493049 0.81 ALDH1A1 (0.37) TSHRALDH1A1MEN1KMT2AGAA
Phosphoric Acid SCHEMBL11090384 0.78 LMNA (0.49) LMNAMAPTTSHRRECQLMAPK1
SCHEMBL10721434 0.76 LMNA (0.42) LMNAMAPTTSHRRECQLMAPK1
SCHEMBL10721429 0.76 LMNA (0.42) LMNAMAPTTSHRRECQLMAPK1
SCHEMBL9492241 0.75 LMNA (0.39) LMNAMAPTTSHRRECQLMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0494047-A1 Use of carbazones for the treatment of rheumatoid diseases CIBA-GEIGY AG (CH) 1992-07-08 — — EP claimed
US-5177091-A Rheumatic disorders CIBA-GEIGY CORPORATION (US) 1993-01-05 — — US disclosed
EP-0494047-A1 Use of carbazones for the treatment of rheumatoid diseases CIBA-GEIGY AG (CH) 1992-07-08 — — EP disclosed
Send feedback